Tag | Content |
---|
EnhancerAtlas ID | HS091-14723 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr15:50123350-50125380 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
MEOX2 | MA0706.1 | chr15:50124885-50124895 | GTTAATTACT | - | 6.02 | NFYA | MA0060.3 | chr15:50123570-50123581 | AGCCAATCAGA | + | 6.32 | Stat6 | MA0520.1 | chr15:50123443-50123458 | AATTTCCAGAGAAAT | + | 6.62 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_35259 | chr15:50123014-50125237 | HeLa |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH15I049831 | chr15 | 50123365 | 50125070 |
|
Enhancer Sequence | TGTGAAATCC TCTTTGAAGG TATTCTCTAG CACTGTGCCT GGCATATGGT GACCCCTCCA 60 ATATTTATAG AAAAAATGAG TGTGCATCAA GGTAATTTCC AGAGAAATTA TCTTCTCAGG 120 AAATTTTCTC TGGAAATTAC CTTGATGTAC AGGTAATTTG TCCATTCCAG GAATATGGCA 180 TGGACTAATT TTAGAGAAAT TAATAGCAAT TATGCCAAAG AGCCAATCAG AAACTGCTTA 240 GTCACCTCTG CTTCTGACCC CTGAAGAGGA CATTCATCTC TGAGATAGGT ACTCATCCTC 300 TTCAGTGATT ACCACAGGGA CTTGGAGGCC CCTTCAAAGC TAAAACCTCC TCTCACCATG 360 GCCCAGGCAA CATCATCAAA ACATCTTGTC TGAGCTCAGA GCCTGGGACC CTAGCCACAC 420 ACTCCTGTCT TCTGAAGAAA CATCTTTCTT CACAGGGCAG GACCTAGGAA GCATGATTTA 480 TCACGAATCA GGGAAAACCC AGGGAAAGTG AGGGCTGCTG TGGTTTCTCC TCTTCCTGTG 540 GAAAGGTCAG TTGATCCTGG GCCTGAGCTC TCCCATGGAG CCTGGGATGC TCGCCTGATG 600 TCACTGATCT GTTCACTTGG CTTCACAGCC TCTCCTTCTC CTCCCCCCAG GGCCAGGATA 660 ACACCTCAGG GGACTCACAT CTGATTCATA CCAGACGTCG AGAGGAAGGA AATGAAAAGT 720 GAGGACAGAC ATTCCTTCCC TCGGCTGAGT GGAAGTCCCA GTAGTCATAA TAACTAGCAG 780 TCACTGAACA TGTGTGGTAT GCCAGCCACT GTGCTAAGGA CTATAATGCA CAGTAAATGT 840 TAACTCTTCC AGTTACTGAG TGCTTACTCT GTACCAGCCA CTATTCCAGG AGCTTTACAA 900 GTATTATTTC ATTTAATCCT TGTGACAACC CCATGAGATG AATCCTATTA TTATCACCAT 960 TTTACAGATA GGAAAACTGA AGTAGGGAGA GAAGAATTAA CTTTCCCAGG GCCACAGAGC 1020 TGAAATGTGA TAGAAGAAGG TTTGAACTTA GACAGCCTGG CTTGAGAATC CATTCATTTA 1080 ACTGTTAAAA TATATGAACA AATTCTTACA AGTCCTCTGT GGTGATTACC ACCTTCCCAT 1140 TTTCAGATGA GGAAGCTGAG ATTCTGCTAA TGTTAAATGA CTGGGGTGAG ATGTGGAAGC 1200 AACTAACTGG GGTAGGAAGA ATGTGATTTC ATTCTGGTCC CAGGTCCTTA GCTCCTTCCA 1260 TAGCATCATG TTGTGTAGGA GATCGGTCAG AGTGGTAGGA GAAGCTATAA GGAAAGACGC 1320 AAACCTTCTT GAAAGGTGGG AAGGTCTTGC AAAAGCTTCC GGAGAGAATA AAGCTGAAGG 1380 CAGCTAATTC TCTCACCCTG ACGCTAAGGG CGAGGACTCC GTAACAAGGG AGTGTAAAGA 1440 AATCTATCTA GAAAAGCTTA TTTACTTATG TCATCCAGAG ACCAACCTTT GATCATCCGC 1500 GCACAAGACT GCTCCCTGCA AGAGGGGACA ACAGTGTTAA TTACTCACAG ATTGTGTTGG 1560 TTCCAGGCCT TTGACATTAT ACCAGTATTG AATAAATACA TGCAGCTCTG GCTTATCAGG 1620 GCTGCTGACT CTTCCGCCAC CTAGTGCCAG GCAGTCCCCT AGCTACTCTC ACGGGATACC 1680 TGTGTCTGAC TACTCCTTTC ATCTGTTGCT CAGCCAGGGT CTGTGGGACA AACCCTGCAG 1740 CTGGTGCTCC ATGTGAGGAA TGCTGCAACA GATCACAATG GAACCTTCAA AAATGAAGGT 1800 GAAGAGACTG TGCAGTCAGT AAGTCATTGG TGCCCACTCA GGATTTCCAA GTTTGAGGGA 1860 ATTTTCAGGT TAGGGTTTCA TCATGAGACA ACAGTTATCA GCTCAACAGA AACAGTATAT 1920 AAAAATATTG AAATAGCTGC TTAAAGCTAG CAGAGCCTCA GTTTCACAGG CTCAATTAAG 1980 GGACCTAAAG CAAACTTTCC CATAACCCAT AGTTCTGGAA GAAGGCATGC 2030
|